Composition having enhanced opsonic activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 1, 1983
Grant Date -
N/A
app pub date -
Jul 2, 1982
filing date -
Jul 2, 1982
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
There is disclosed a pharmaceutical composition for therapeutic use comprising an immune globulin and fibronectin in amounts sufficient to produce an opsonic activity in the composition that is greater than the additive opsonic activity of the individual agents or in amounts sufficient to produce a phagocytosis of infectious agents greater than the additive effect from fibronectin and immune globulin alone.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully